FDA rejects Pfizer’s Herceptin biosimilar
US regulators have issued a complete response letter regarding Pfizer’s filing for a biosimilar version of Roche’s blockbuster cancer drug Herceptin.
Read Moreby Selina McKee | Apr 24, 2018 | News | 0
US regulators have issued a complete response letter regarding Pfizer’s filing for a biosimilar version of Roche’s blockbuster cancer drug Herceptin.
Read Moreby Selina McKee | Jul 10, 2017 | News | 0
Pfizer’s new meningitis B vaccine Trumenba is now available in the UK for teens and young adults providing an additional option for vaccination against the disease.
Read Moreby Selina McKee | May 31, 2017 | News | 0
Pfizer’s Trumenba has been cleared by European regulators to help prevent infection with meningococcal group B disease in adolescents and adults.
Read Moreby Selina McKee | Mar 27, 2017 | News | 0
Six new medicines, including three orphan drugs for rare diseases, have been backed for European Union approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
